Cargando…
The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication
OBJECTIVES: The primary objective of this pilot study was to determine if the Medication Event Monitoring System (MEMS) is capable of providing meaningful estimates of compliance within the indigenous Qatari population. The secondary objective was to highlight any specific problems which might be as...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915557/ https://www.ncbi.nlm.nih.gov/pubmed/20694184 |
_version_ | 1782184937822093312 |
---|---|
author | Kheir, Nadir Greer, William Yousif, Adil Al-Geed, Hajer Okkah, Randa Al Zirie, Mahmoud Sandridge, Amy Zaidan, Manal |
author_facet | Kheir, Nadir Greer, William Yousif, Adil Al-Geed, Hajer Okkah, Randa Al Zirie, Mahmoud Sandridge, Amy Zaidan, Manal |
author_sort | Kheir, Nadir |
collection | PubMed |
description | OBJECTIVES: The primary objective of this pilot study was to determine if the Medication Event Monitoring System (MEMS) is capable of providing meaningful estimates of compliance within the indigenous Qatari population. The secondary objective was to highlight any specific problems which might be associated with the use of MEMS within this population. METHOD: A sample of adult diabetic Qatari patients attending an outpatient diabetic clinic were administered a Knowledge, Attitude, and Practices (KAP) questionnaire and then dispensed one of their regular medications in a MEMS(®)-fitted bottle. Data contained in the MEMS(®) were downloaded after the patients returned for a refill and adherence was estimated using 2 methods: pill count and MEMS(®) data. RESULTS: A total of 54 patients agreed to participate in this pilot study. Adherence to daily doses was 67.7% and with regimen 13.7%. No correlation was found between adherence assessed by pill count and MEMS(®). The association between KAP and adherence was generally poor. A number of other issues and challenges in the use of MEMS(®) that could affect its utility were noted and will be discussed. CONCLUSIONS: Our results revealed problems associated with the use of MEMS(®) that could affect its usefulness in assessing adherence in this part of the world. Some issues identified in this pilot study included retrieving the MEMS(®), registering extra opening of MEMS(®), desire to hoard medicine by taking doses at different frequency than recorded in MEMS(®). All these issues could be closely associated with the attitudes and practices of the patients, as demonstrated by our KAP analysis and correlations. |
format | Text |
id | pubmed-2915557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29155572010-08-06 The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication Kheir, Nadir Greer, William Yousif, Adil Al-Geed, Hajer Okkah, Randa Al Zirie, Mahmoud Sandridge, Amy Zaidan, Manal Patient Prefer Adherence Original Research OBJECTIVES: The primary objective of this pilot study was to determine if the Medication Event Monitoring System (MEMS) is capable of providing meaningful estimates of compliance within the indigenous Qatari population. The secondary objective was to highlight any specific problems which might be associated with the use of MEMS within this population. METHOD: A sample of adult diabetic Qatari patients attending an outpatient diabetic clinic were administered a Knowledge, Attitude, and Practices (KAP) questionnaire and then dispensed one of their regular medications in a MEMS(®)-fitted bottle. Data contained in the MEMS(®) were downloaded after the patients returned for a refill and adherence was estimated using 2 methods: pill count and MEMS(®) data. RESULTS: A total of 54 patients agreed to participate in this pilot study. Adherence to daily doses was 67.7% and with regimen 13.7%. No correlation was found between adherence assessed by pill count and MEMS(®). The association between KAP and adherence was generally poor. A number of other issues and challenges in the use of MEMS(®) that could affect its utility were noted and will be discussed. CONCLUSIONS: Our results revealed problems associated with the use of MEMS(®) that could affect its usefulness in assessing adherence in this part of the world. Some issues identified in this pilot study included retrieving the MEMS(®), registering extra opening of MEMS(®), desire to hoard medicine by taking doses at different frequency than recorded in MEMS(®). All these issues could be closely associated with the attitudes and practices of the patients, as demonstrated by our KAP analysis and correlations. Dove Medical Press 2010-07-21 /pmc/articles/PMC2915557/ /pubmed/20694184 Text en © 2010 Kheir et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Kheir, Nadir Greer, William Yousif, Adil Al-Geed, Hajer Okkah, Randa Al Zirie, Mahmoud Sandridge, Amy Zaidan, Manal The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title_full | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title_fullStr | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title_full_unstemmed | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title_short | The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
title_sort | utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915557/ https://www.ncbi.nlm.nih.gov/pubmed/20694184 |
work_keys_str_mv | AT kheirnadir theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT greerwilliam theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT yousifadil theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT algeedhajer theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT okkahrandaal theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT ziriemahmoud theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT sandridgeamy theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT zaidanmanal theutilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT kheirnadir utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT greerwilliam utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT yousifadil utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT algeedhajer utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT okkahrandaal utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT ziriemahmoud utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT sandridgeamy utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication AT zaidanmanal utilityofanelectronicadherenceassessmentdeviceintype2diabetesmellitusapilotstudyofsinglemedication |